Volume 53, Issue 37 pp. 9936-9939
Communication

High Performance of a Palladium Phosphinooxazoline Catalyst in the Asymmetric Arylation of Cyclic N-Sulfonyl Ketimines

Chunhui Jiang

Chunhui Jiang

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543 (Singapore)

Search for more papers by this author
Prof. Dr. Yixin Lu

Corresponding Author

Prof. Dr. Yixin Lu

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543 (Singapore)

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543 (Singapore)Search for more papers by this author
Prof. Dr. Tamio Hayashi

Corresponding Author

Prof. Dr. Tamio Hayashi

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543 (Singapore)

Institute of Materials Research and Engineering, A*STAR, 3 Research Link, Singapore 117602 (Singapore)

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543 (Singapore)Search for more papers by this author
First published: 18 July 2014
Citations: 113

We thank the National University of Singapore and the Ministry of Education (MOE) of Singapore (R-143-000-362-112 and R-143-000-539-133) for financial support.

Graphical Abstract

Chiral cyclic sulfamidates are obtained by the asymmetric addition of arylboronic acids to six-membered cyclic N-sulfonyl ketimines. A cationic palladium complex with a chiral phosphine-oxazoline ligand (iPr-phox) shows high catalytic activity and enantioselectivity to give the products in high yields with 96–99.9 % ee. The cyclic sulfamidates exhibit a tetrasubstituted stereogenic center with an amino group and a triaryl or alkyldiaryl group as substituents.

Abstract

A cationic palladium complex with a chiral phosphine-oxazoline ligand (iPr-phox) showed high catalytic activity and enantioselectivity in the asymmetric addition of arylboronic acids to six-membered cyclic N-sulfonyl ketimines to give high yields of the corresponding chiral cyclic sulfamidates with 96–99.9 % ee. The products have tetrasubstituted stereogenic centers with an amino group and a triaryl or alkyldiaryl group as substituents.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.